Trials / Completed
CompletedNCT03265340
Clinical Effect of dTMS in Major Depressive Disorder
Clinical Effect of Deep Transcranial Magnetic Stimulation (dTMS) in Three Different Doses for the Treatment of Major Depressive Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Section for Affective Disorders; Northern Stockholm Psychiatry · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Aim: To test if there is a relation between deep Transcranial Magnetic Stimulation (dTMS) dose and clinical effect on Major Depressive Disorder (MDD) Method: 30 patients with moderate to severe MDD without concurrent medication will be randomised to three different treatment protocols of dTMS. Symptom severity of MDD will be quantified before, during and after dTMS.
Detailed description
population: inclusion criteria: 1. Ongoing episode of MDD (ICD10 F32.x) according to MINI/SCID1. 2. Montgomery Asberg Depression Rating Scale (MADRS) score 20-60 3. TMS safe exclusion criteria: 1\. Bipolar disorder 2. Substance abuse 3. fluoxetine treatment last three weeks 4. Other major Central Nervous System (CNS) disorder 5. Acute medical disorders 6. previous TMS or Electro Convulsive Treatment (ECT) \<2 months before inclusion ratings: MADRS at inclusion, baseline, weekly, at last visit Clinical Global Impression Severity (CGI-S) score at baseline, at last visit Global Self-Evaluation-Memory (GSE-My) at last visit Alcohol Use Disorder Identification Test (AUDIT-C) at inclusion EuroQual 5 Dimension (EQ5D) at baseline, at last visit Quick Inventory of Depressive Symptomatology Self Rating (QIDS-SR) baseline, weekly, last visit condition: Each subject is randomised to condition A, B or C of dTMS (Brainsway): half the standard protocol (10 min; A), standard protocol (20 min; B) or double standard protocol (40 min, C). 20 treatment sessions/subject. 10 subjects in each group. Primary endpoint: MADRS at baseline - MADRS at last visit (Intention TO Treat (ITT), Last Observation Carried Forward (LOCF))
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | dTMS |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2017-08-29
- Last updated
- 2019-03-13
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03265340. Inclusion in this directory is not an endorsement.